ADVAXIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Advaxis, Inc. - ADXS
NEW ORLEANS--(BUSINESS WIRE)--Jul 7, 2021--
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Advaxis, Inc. (NasdaqGS: ADXS) (“the Company”) with Biosight Ltd. pursuant to which Advaxis shareholders will own approximately 25% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.
If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( firstname.lastname@example.org ) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-adxs/ to learn more.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210707005877/en/
CONTACT: Kahn Swick & Foti, LLC
Lewis S. Kahn, Managing Partner, 855-768-1857
KEYWORD: UNITED STATES NORTH AMERICA LOUISIANA
INDUSTRY KEYWORD: BIOTECHNOLOGY LEGAL PROFESSIONAL SERVICES HEALTH
SOURCE: Kahn Swick & Foti, LLC
Copyright Business Wire 2021.
PUB: 07/07/2021 03:47 PM/DISC: 07/07/2021 03:47 PM